Richard Bennett

Cardiology and Electrophysiology Registrar, Bristol Heart Institute. PhD candidate, Westmead Hospital, University of Sydney

[Jason Andrade @DrJasonAndrade]

If you ever wondered whether AF progression differs based on the randomized PVI ablation energy please consider joining our ESC late breaking clinical trial update next Friday at 14:00

@peterkistler3 and @nmarrouche will also be presenting on PWI, and AI

https://t.co/lz5mz81doI

[Richard Bennett @RBennett_EP]

@SaurabhkumarEp @SamTurnbull_ @WARC_USYD @RENWestmead Amazing! Congratulations guys! So proud of you both too!

[Jason Andrade @DrJasonAndrade]

Our recent review on asymptomatic AF - in it we discuss important management differences between asymptomatic AF and Subclinical/DDAF.

@MarcDeyell @RBennett_EP

https://t.co/PxmPyDQncX

[Richard Bennett @RBennett_EP]

@CardioUBC Thank you! I’m honoured and very excited to be able to start my career here in Vancouver. I’m looking forward to working with everyone to keep providing the best possible care for all of our patients.

[Jason Andrade @DrJasonAndrade]

We know progression from paroxysmal AF to persistent AF is associated with worse outcomes.

And we know Cryoballoon ablation decreases progression vs AAD therapy.

Join us at ESC for late-breaking science comparing cryoballoon ablation and RF ablation

https://t.co/dO410eFTg3

[JICE @JICE_EP]

🚨Newest #OpenAccess Article in @JICE_EP

Efficacy & Safety of Catheter Ablation as First-Line therapy for the Management of VT

by @KotakeYasuhito K Huang R Bennett, @kasundesilva_ @JulianaKanawati T Campbell, @SaurabhkumarEp & Colleagues

📖☕️ https://t.co/8lIHbPX261

#EPeeps

[Richard Bennett @RBennett_EP]

@drashnisbet @DrJasonAndrade @DrNatHawkins Thank you for your kind words Ashley. I’m so grateful for everything that everyone at Bristol has done for me and it genuinely is very sad to say goodbye. Looking forward to the amazing opportunity that awaits in Vancouver. Please come and visit!

[CircEP @CirculationEP]

Early Catheter Ablation Versus Initial Medical Therapy for Ventricular Tachycardia Storm #AHAJournals #Epeeps @clara_chow @adameslick1 @priestley608 @SaurabhkumarEp https://t.co/og5STUFri0

[James Chong @jameschong_doc]

Excited to share our new preprint: mechanism+treatment of Human Pluripotent Stem Cell Cardiomyocyte graft related arrhythmias ⁦@dinukumar88⁩ ⁦@claytonzed⁩ ⁦@SaurabhkumarEp⁩ ⁦@abjprowse⁩ ⁦@BeardedHeartDoc⁩ ⁦@n_palpant⁩ https://t.co/bEC2XIqO03

[Westmead Applied Research Centre #WARC_USYD @WARC_USYD]

In this systematic review, the substrate for VA in #Brugada wasn’t just localised to the epicardial RVOT! Catheter ablation was safe and efficacious. See our work here: https://t.co/pmVREFsYAe #TeamVTWestmead

[Westmead Applied Research Centre #WARC_USYD @WARC_USYD]

What do you do when a patient experiences recurrent PVC-triggered VF in the acute phase post STEMI and all drugs have failed? Check out our recent paper, describing a "bail-out" strategy for VF storm ablation in acute phase of myocardial infarction here: https://t.co/JWyH71rFkj

[Westmead Applied Research Centre #WARC_USYD @WARC_USYD]

CA is safe & efficacious in pts with prior aortic/mitral valve intervention. Scar is perivalvular (PV) in 81%. But PV-related VT circuits were only present in 52% of pts & 9% had non-scar related VT!
See our paper here 👇
https://t.co/NTvrDFfmoE
#AblateVT